Literature DB >> 3336543

Diagnosis of recurrent cervical carcinoma after radical hysterectomy.

D M Larson1, L J Copeland, J M Malone, C A Stringer, D M Gershenson, C L Edwards.   

Abstract

A standard surveillance program for cervical carcinoma patients treated with radical hysterectomy is reviewed. Between 1962-1984, 249 patients with stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy were entered in the surveillance program. Of the 27 patients (11%) diagnosed with recurrent carcinoma, 17 (63%) were identified by clinical history, 22 (81%) by physical examination, five (18%) by vaginal cytology, six (22%) by chest radiography, and eight (30%) by renal contrast imaging. Combined clinical history and physical examination identified 24 patients (89%) with recurrent carcinoma. Disease recurrence was detected by vaginal cytology in one asymptomatic patient with a normal examination. The recommended surveillance procedures for patients with cervical carcinoma after radical hysterectomy include clinical history, physical examination, and vaginal cytology. Chest radiography and renal contrast imaging should be reserved for symptomatic patients.

Entities:  

Mesh:

Year:  1988        PMID: 3336543

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Follow-up for women after treatment for cervical cancer.

Authors:  L Elit; A W Fyles; T K Oliver; M C Devries-Aboud; M Fung-Kee-Fung
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

2.  The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis.

Authors:  Kanyarat Katanyoo; Arthorn Riewpaiboon; Usa Chaikledkaew; Montarat Thavorncharoensap
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

Review 3.  Follow-up protocols for women with cervical cancer after primary treatment.

Authors:  Anne Lanceley; Alison Fiander; Mary McCormack; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2013-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.